The World Health Organization (WHO) has issued guidelines regarding the use of the antivirals (Tamiflu and Relenza) for people infected with the H1N1 virus. The goal of antivirals is to reduce the amount of hospital care need to treat patients who have developed severe complications of influenza and limit the number of deaths.
The WHO has already identified the people who are highest risk of developing these severe complications should they contract the H1N1 virus. Considering the limited time that doctors have to give the antivirals (within 48 hours of onset of illness), the WHO has recommended that if patients come …read more